HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Yao Selected Research

Breast Neoplasms (Breast Cancer)

10/2022EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation.
1/2021TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer.
1/2021Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.
1/2021Injectable and Temperature-Sensitive Titanium Carbide-Loaded Hydrogel System for Photothermal Therapy of Breast Cancer.
3/2020Gö6983 attenuates breast cancer-induced osteolysis by the apoptotic pathway.
11/2019CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer.
1/2019Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
1/2019Sphingosine Kinase 1 Signaling Promotes Metastasis of Triple-Negative Breast Cancer.
1/2018The Alu-insertion progesterone receptor gene polymorphism is not associated with breast cancer: a meta-analysis.
12/2017JAK2-binding long noncoding RNA promotes breast cancer brain metastasis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Yao Research Topics

Disease

113Neoplasms (Cancer)
10/2022 - 08/2002
36Breast Neoplasms (Breast Cancer)
10/2022 - 09/2003
24Schizophrenia (Dementia Praecox)
05/2022 - 03/2013
23Inflammation (Inflammations)
01/2022 - 06/2010
22Infections
12/2021 - 03/2004
21Neoplasm Metastasis (Metastasis)
10/2022 - 04/2010
19Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2007
17Stomach Neoplasms (Stomach Cancer)
12/2021 - 09/2012
16Carcinogenesis
01/2022 - 09/2009
15Hepatitis B
02/2021 - 02/2006
12Hypoxia (Hypoxemia)
01/2021 - 02/2010
11Carcinoma (Carcinomatosis)
05/2022 - 08/2006
11Hepatocellular Carcinoma (Hepatoma)
04/2021 - 11/2009
11Bacterial Infections (Bacterial Infection)
01/2017 - 01/2014
10Colitis
01/2022 - 05/2010
10Triple Negative Breast Neoplasms
01/2022 - 09/2014
10Ulcerative Colitis
01/2022 - 05/2010
10Alzheimer Disease (Alzheimer's Disease)
01/2020 - 12/2002
9Osteoarthritis
12/2021 - 01/2018
9Stroke (Strokes)
10/2021 - 12/2005
9Glioma (Gliomas)
01/2021 - 07/2011
8Body Weight (Weight, Body)
01/2022 - 09/2006
8Hearing Loss (Hearing Impairment)
10/2021 - 07/2013
7Hemorrhage
01/2022 - 01/2015
7Deafness (Deaf Mutism)
01/2020 - 11/2002
6Type 2 Diabetes Mellitus (MODY)
11/2022 - 09/2006
6Fibrosis (Cirrhosis)
01/2022 - 08/2010
6Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 12/2013
6Osteolysis
03/2020 - 01/2018
6Glioblastoma (Glioblastoma Multiforme)
06/2015 - 07/2011
5Esophageal Squamous Cell Carcinoma
06/2022 - 12/2017
5Melanoma (Melanoma, Malignant)
04/2022 - 04/2014
5Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 05/2016
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2022 - 08/2019
5Adenocarcinoma
01/2022 - 09/2014
5Necrosis
10/2021 - 12/2006
5Mental Disorders (Mental Disorder)
01/2021 - 03/2013
5Insulin Resistance
06/2020 - 02/2012
5Brain Injuries (Brain Injury)
01/2019 - 12/2005
4Hepatitis A (Hepatitis, Infectious)
11/2022 - 09/2003
4Shock
01/2021 - 01/2016
4Pathologic Processes
01/2021 - 08/2012
4Adenoma (Adenomas)
09/2020 - 01/2019
4Lung Neoplasms (Lung Cancer)
01/2020 - 04/2014
4Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 10/2009

Drug/Important Bio-Agent (IBA)

60Proteins (Proteins, Gene)FDA Link
04/2022 - 03/2007
21DNA (Deoxyribonucleic Acid)IBA
03/2022 - 09/2003
18MicroRNAs (MicroRNA)IBA
05/2022 - 01/2013
18Pharmaceutical PreparationsIBA
04/2022 - 06/2007
17Biomarkers (Surrogate Marker)IBA
05/2022 - 08/2010
15CytokinesIBA
01/2022 - 08/2003
13Messenger RNA (mRNA)IBA
01/2022 - 04/2010
12RNA (Ribonucleic Acid)IBA
03/2022 - 02/2012
11Small Interfering RNA (siRNA)IBA
01/2022 - 09/2007
11Biological ProductsIBA
12/2021 - 02/2012
9Phosphotransferases (Kinase)IBA
04/2020 - 06/2007
8Glucose (Dextrose)FDA LinkGeneric
11/2022 - 10/2010
8Long Noncoding RNAIBA
04/2022 - 01/2017
8Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2020 - 02/2006
7Hepatitis B Vaccines (Hepatitis B Vaccine)IBA
11/2022 - 11/2012
7EnzymesIBA
01/2021 - 04/2005
6VaccinesIBA
11/2022 - 02/2006
6Circular RNAIBA
06/2022 - 12/2019
6KetamineFDA LinkGeneric
05/2022 - 01/2019
6ORALIT (ORS)IBA
01/2022 - 12/2015
6Phenobarbital (Luminal)FDA Link
01/2021 - 07/2010
6NF-kappa B (NF-kB)IBA
07/2017 - 12/2006
5Amyloid beta-PeptidesIBA
04/2022 - 07/2003
5AntioxidantsIBA
01/2022 - 05/2010
5Dextran SulfateIBA
01/2022 - 04/2011
5Interleukin-6 (Interleukin 6)IBA
09/2021 - 02/2011
5CateninsIBA
05/2021 - 09/2013
5Therapeutic UsesIBA
01/2021 - 06/2007
5Neurotransmitter Agents (Neurotransmitter)IBA
12/2020 - 03/2013
5Serotonin (5 Hydroxytryptamine)IBA
01/2020 - 12/2012
5AntibodiesIBA
01/2020 - 09/2003
5Glycoproteins (Glycoprotein)IBA
10/2019 - 10/2009
5ErbB Receptors (EGF Receptor)IBA
01/2018 - 01/2013
5pleiotrophin (HARP)IBA
06/2017 - 09/2007
5ProteomeIBA
01/2017 - 08/2010
4Insulin (Novolin)FDA Link
11/2022 - 02/2011
4Transforming Growth Factor beta (TGF-beta)IBA
10/2022 - 08/2002
4Tumor Biomarkers (Tumor Markers)IBA
06/2022 - 11/2018
4Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
05/2022 - 01/2014
4Protein Isoforms (Isoforms)IBA
01/2022 - 08/2004
4Histones (Histone)IBA
01/2022 - 12/2010
4Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2022 - 06/2015
4Immune Checkpoint InhibitorsIBA
12/2021 - 01/2019
4Antiviral Agents (Antivirals)IBA
12/2021 - 10/2014
4Glutamic Acid (Glutamate)FDA Link
01/2021 - 09/2008
4Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 10/2017
4LigandsIBA
01/2021 - 10/2017
4B7-H1 AntigenIBA
01/2021 - 12/2018
4oxysterol binding proteinIBA
01/2020 - 05/2016
4Transcription Factors (Transcription Factor)IBA
01/2020 - 12/2006

Therapy/Procedure

48Therapeutics
10/2022 - 04/2006
13Drug Therapy (Chemotherapy)
01/2022 - 09/2003
11Immunotherapy
10/2022 - 04/2014
5Ligation
01/2022 - 02/2011
5Oral Administration
01/2021 - 07/2010